Premature and critically ill neonates in the neonatal intensive care unit commonly receive platelet transfusions to prevent bleeding. Observational data and randomized trials have associated higher transfusion thresholds with increased mortality, bleeding, lung disease, and neurodevelopmental impairment in this population, leading to concern that transfusions may provoke harmful inflammation. One hypothesized contributor is a developmental mismatch: neonates receive platelets from adult donors even though neonatal platelets differ functionally from adult platelets. Platelets interact with innate immune cells and can regulate monocyte inflammatory responses, but the impact of platelet developmental stage on monocyte behavior has not been fully defined.
This study modeled the transfusion‑relevant developmental mismatch in vitro to examine how exposure of neonatal (cord blood) monocytes to either neonatal or adult platelets affects monocyte inflammatory signaling and migratory phenotype.
The investigators used an experimental system in which monocytes isolated from neonatal cord blood were exposed to platelets derived from either cord blood (neonatal platelets) or adult donors (adult platelets). The design aimed to recapitulate cellular interactions that occur when an infant receives adult donor platelets. Outcomes assessed included platelet activation markers and secreted products, monocyte cytokine release, and monocyte surface expression of chemokine receptors associated with migration.
When activated, adult platelets expressed higher levels of surface P‑selectin than neonatal platelets. In addition, adult platelets released more beta‑2‑microglobulin (B2M) after activation compared with neonatal platelets. These observations demonstrate measurable developmental differences in platelet activation phenotype and secreted factors that could influence downstream immune cell responses.
Exposure of neonatal monocytes to platelets of either developmental stage increased release of the chemokines IL‑8 and MCP‑1. The magnitude of cytokine induction was similar after exposure to neonatal or adult platelets, indicating that monocyte cytokine release in this system was not dependent on the platelet developmental stage or on differences in platelet P‑selectin expression.
In contrast to cytokine release, monocyte expression of the chemokine receptors CCR2 and CCR5 was differentially affected by platelet developmental stage. Neonatal monocytes exposed to adult platelets upregulated surface CCR2 and CCR5 to a significantly greater degree than when exposed to neonatal platelets. Increased CCR2 and CCR5 are consistent with a more pro‑migratory monocyte phenotype, priming monocytes to exit the circulation and migrate into tissues.
To probe mechanisms, the study examined the effect of blocking P‑selectin/PSGL‑1 interactions. Inhibiting this ligand–receptor pair had no measurable effect on platelet‑induced monocyte IL‑8 or MCP‑1 release, consistent with cytokine induction being mediated by other platelet signals. However, blocking P‑selectin/PSGL‑1 interactions completely abrogated the upregulation of monocyte CCR2 and CCR5 induced by platelets. These findings indicate that platelet P‑selectin engagement of monocyte PSGL‑1 is necessary for the shift toward a migratory phenotype, and that the higher P‑selectin exposure on adult platelets drives this effect.
The results suggest a mechanistic pathway by which transfusion of adult platelets into neonates could prime circulating monocytes for tissue migration via platelet P‑selectin. Because cytokine induction occurred with both neonatal and adult platelets, the unique contribution of adult platelets appears to be the promotion of a pro‑migratory monocyte phenotype through P‑selectin/PSGL‑1 interactions. In clinical terms, this could contribute to inflammatory tissue injury after transfusion and may help explain associations between platelet transfusion strategies and adverse outcomes in neonates.
These findings support further investigation into whether matching platelet transfusion products to recipient developmental stage—or modifying donor platelet P‑selectin exposure—could reduce undesired monocyte priming and inflammation. They also underscore the need to better characterize how platelet immune functions change with age and how those differences affect host immune responses when adult platelets are transfused into neonates.
This in vitro study demonstrates that adult platelets express more surface P‑selectin and release more B2M after activation than neonatal platelets, and that these developmental differences selectively regulate neonatal monocyte migratory priming via P‑selectin/PSGL‑1. Monocyte chemokine release (IL‑8 and MCP‑1) increased after platelet exposure irrespective of platelet developmental stage and was not altered by blocking P‑selectin/PSGL‑1.
The findings recommend additional translational and clinical research to determine whether developmental matching of platelet products or targeted modulation of platelet–monocyte interactions can reduce transfusion‑associated inflammation and improve outcomes in neonatal critical care. Details such as sample sizes, specific assay conditions, and quantitative effect sizes were not reported in the abstract and should be consulted in the full article for experimental specifics.